MHRA approves first drug via the new IRP in 30 days
XGEVA is the first product to be authorised by the regulator through the new International Recognition Procedure (IRP).
The latest formulation of XGEVA (denosumab)...
This site is intended for Healthcare Professionals only.
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc
This site is intended for Healthcare Professionals only.